This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stanton, V P Articles by Cooper, G M Search for Related Content PubMed PubMed Citation Articles by Stanton, V P, Jr Articles by Cooper, G M

Activation of human raf transforming genes by deletion of normal amino-terminal coding sequences.

ABSTRACT

Three activated cellular raf genes have been detected by transfection of NIH 3T3 cells with human tumor DNAs. Blot hybridization analysis indicated that all three transforming raf genes had recombined with non-raf sequences in the vicinity of raf exon 7-intron 7, resulting in the deletion of about 40% of the normal coding sequence from the raf amino terminus. By cloning sequences upstream of the truncated raf loci we have shown that the rearrangements involve the fusion of three different 5' non-raf human sequences to the human raf gene. No rearrangements could be detected in the raf loci of the three original human tumor DNAs, suggesting that the raf genes were activated by DNA rearrangements occurring during transfection. Significant overexpression of raf mRNA was not evident in two of the three transformant lines, indicating that raf overexpression is not necessary and 5' truncation alone may be sufficient to activate the transforming potential of cellular raf genes.

This article has been cited by other articles:

• Beeram, M., Patnaik, A., Rowinsky, E. K. (2005). Raf: A Strategic Target for Therapeutic Development Against Cancer. JCO 23: 6771-6790 [Abstract] [Full Text]  
• Chong, H., Guan, K.-L. (2003). Regulation of Raf through Phosphorylation and N Terminus-C Terminus Interaction. J. Biol. Chem. 278: 36269-36276 [Abstract] [Full Text]  
• Tolcher, A. W., Reyno, L., Venner, P. M., Ernst, S. D., Moore, M., Geary, R. S., Chi, K., Hall, S., Walsh, W., Dorr, A., Eisenhauer, E. (2002). A Randomized Phase II and Pharmacokinetic Study of the Antisense Oligonucleotides ISIS 3521 and ISIS 5132 in Patients with Hormone-refractory Prostate Cancer. Clin. Cancer Res. 8: 2530-2535 [Abstract] [Full Text]  
• Cripps, M. C., Figueredo, A. T., Oza, A. M., Taylor, M. J., Fields, A. L., Holmlund, J. T., McIntosh, L. W., Geary, R. S., Eisenhauer, E. A. (2002). Phase II Randomized Study of ISIS 3521 and ISIS 5132 in Patients with Locally Advanced or Metastatic Colorectal Cancer: A National Cancer Institute of Canada Clinical Trials Group Study. Clin. Cancer Res. 8: 2188-2192 [Abstract] [Full Text]  
• Woods, D., Cherwinski, H., Venetsanakos, E., Bhat, A., Gysin, S., Humbert, M., Bray, P. F., Saylor, V. L., McMahon, M. (2001). Induction of {beta}3-Integrin Gene Expression by Sustained Activation of the Ras-Regulated Raf-MEK-Extracellular Signal-Regulated Kinase Signaling Pathway. Mol. Cell. Biol. 21: 3192-3205 [Abstract] [Full Text]  
• Aplin, A. E., Stewart, S. A., Assoian, R. K., Juliano, R.L. (2001). Integrin-mediated adhesion Regulates ERK Nuclear Translocation and Phosphorylation of Elk-1. J. Cell Biol. 153: 273-282 [Abstract] [Full Text]  
• O'Dwyer, P. J., Stevenson, J. P., Gallagher, M., Cassella, A., Vasilevskaya, I., Monia, B. P., Holmlund, J., Dorr, F. A., Yao, K.-S. (1999). c-raf-1 Depletion and Tumor Responses in Patients Treated with the c-raf-1 Antisense Oligodeoxynucleotide ISIS 5132 (CGP 69846A). Clin. Cancer Res. 5: 3977-3982 [Abstract] [Full Text]  
• Abe, K., Whitehead, I. P., O'Bryan, J. P., Der, C. J. (1999). Involvement of NH2-terminal Sequences in the Negative Regulation of Vav Signaling and Transforming Activity. J. Biol. Chem. 274: 30410-30418 [Abstract] [Full Text]  
• Stevenson, J. P., Yao, K.-S., Gallagher, M., Friedland, D., Mitchell, E. P., Cassella, A., Monia, B., Kwoh, T. J., Yu, R., Holmlund, J., Dorr, F. A., O'Dwyer, P. J. (1999). Phase I Clinical/Pharmacokinetic and Pharmacodynamic Trial of the c-raf-1 Antisense Oligonucleotide ISIS 5132 (CGP 69846A). JCO 17: 2227-2227 [Abstract] [Full Text]  
• Cutler, R. E. Jr., Stephens, R. M., Saracino, M. R., Morrison, D. K. (1998). Autoregulation of the Raf-1 serine/threonine kinase. Proc. Natl. Acad. Sci. USA 95: 9214-9219 [Abstract] [Full Text]  
• Pumiglia, K. M., LeVine, H., Haske, T., Habib, T., Jove, R., Decker, S. J. (1995). A Direct Interaction between G-Protein [IMAGE][IMAGE] Subunits and the Raf-1 Protein Kinase. J. Biol. Chem. 270: 14251-14254 [Abstract] [Full Text]  
• Whitehurst, C. E., Owaki, H., Bruder, J. T., Rapp, U. R., Geppert, T. D. (1995). The MEK Kinase Activity of the Catalytic Domain of RAF-1 Is Regulated Independently of Ras Binding in T Cells. J. Biol. Chem. 270: 5594-5599 [Abstract] [Full Text]  
• Hall, A (1994). A biochemical function for ras--at last. Science 264: 1413-1414  
• Wolfes, H, Kogawa, K, Millette, C., Cooper, G. (1989). Specific expression of nuclear proto-oncogenes before entry into meiotic prophase of spermatogenesis. Science 245: 740-743 [Abstract]  
• Reynolds, S., Stowers, S., Patterson, R., Maronpot, R., Aaronson, S., Anderson, M. (1987). Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science 237: 1309-1316 [Abstract]